The National Institutes of Health National Cancer Institute awarded a $160,000 firm fixed price Blanket Purchase Agreement Call contract to the Department of Health and Healthcare Products Regulatory Agency for a 12-month license providing access to National Library of Medicine United Kingdom Clinical Practice Research Datalink datasets. The contract has no set-aside designation. Under this contract, the Department of Health and Healthcare Products Regulatory Agency will deliver requested access...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute provides the prime contractor, the United Kingdom's Department of Health known as the Medicines & Healthcare Products Regulatory Agency, with a license to access the Clinical Practice Research Datalink (CPRD) National Cancer Data Registry (NCDR) database. Valued at one hundred seventy-three thousand one hundred...
This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...
This is a firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract provides the National Institutes of Health's (NIH) National Cancer Institute with access to the UK Clinical Practice Research Datalink (CPRD) database of de-identified patient data, as well as linkages to other registries, to support the agency's epidemiological...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The contract provides the NCI with access to the Clinical Practice Research Datalink (CPRD) database and linkages to the National Cancer Data Registry, to support the NCI's epidemiological cancer research. Specific studies will...
The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a firm fixed price task order worth $15,281 under an unspecified government-wide acquisition contract vehicle to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The task order calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study reproductive risk...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price contract valued at fifteen thousand two hundred eighty-one dollars to the Department of Health Medicines & Healthcare Products Regulatory Agency. The contract calls for linking clinical practice data from the Clinical Practice Research Datalink to the National Cancer Data Registry database to study the relationship between hormone therapy and risks of secondary...
UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
<p>This is a firm-fixed price purchase order award by the National Institutes of Health (NIH), National Cancer Institute, to the Medicines and Healthcare Products Regulatory Agency. The award, valued at $55,960.57, is for payment related to a prior award with contract number 75N91020A00003. The period of performance runs through July 23, 2024. This award does not have a set-aside designation.</p>
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency (MHRA), a UK government agency. The contract, valued at $2,816,500.00, is for the recompete of the General Practice Research Division within the MHRA. It is a firm fixed price contract with no set-aside designation. The contract provides access to the Clinical Practice Research Datalink (CPRD) database and...